Back to Trials
NCT06727578NARecruiting

Pleural Irrigation With a Novel Devise.

Beth Israel Deaconess Medical Center

Start Date

5/25/2025

Completion Date

7/31/2026

Summary

Single-arm pilot trial of the use of intrapleural saline irrigation to treat retained pleural infections for patients with contraindications to standard of care intrapleural enzymatic therapy.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Retained pleural effusion identified via bedside ultrasound within the first 24 hours after chest tube insertion * Patient is contraindicated from receiving intrapleural enzymatic therapy within the first 24 hours after chest tube insertion Exclusion Criteria: * Non-infectious cause of pleural fluid analysis findings listed above identified (e.g. malignancy) * Post-procedural empyema or complicated parapneumonic effusion

Interventions

DEVICE

of intrapleural saline irrigation with CLR irrigator

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pleural Effusion Disorder

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts 02215

United States